Enhancing Breast Cancer Therapy through Killing ‘Sleeper Cells’

Can't see this email? View it online

	Breast Cancer
	The latest breast cancer news from News Medical

Enhancing Breast Cancer Therapy through Killing ‘Sleeper Cells’

AZoLifeSciences speaks to Dr. James Whittle and Professor Geoff Lindeman about their research in enhancing breast cancer therapy through killing sleeper cells.

			Genome Study Links DNA Changes To The Risks Of Breast Cancer Subtypes Genetic studies covering 266,000 women have revealed 32 new sites on the genome where variations in DNA appear to alter the risks of getting breast cancer.

			Honeybee venom rapidly destroys aggressive breast cancer cells Using the venom from 312 honeybees and bumblebees in Perth Western Australia, Ireland and England, Dr Ciara Duffy from the Harry Perkins Institute of Medical Research and The University of Western Australia, tested the effect of the venom on the clinical subtypes of breast cancer, including triple-negative breast cancer, which has limited treatment options.

	Triple-negative breast cancer's ecosystem reveals potential therapeutic targets Researchers from the Garvan Institute of Medical Research have uncovered four new subtypes of cells within triple-negative breast cancer, which contain promising new therapeutic targets for the aggressive disease.

	Researchers Find New Breast Cancer Gene In Young People Over the years, our knowledge of diseases has improved, and several hereditary gene variants have been found that may predispose to the development of cancer.

	Surgical delays did not impact overall survival in patients with early stage breast cancer Beginning in March, as COVID-19 cases surged in various states in the U.S., the COVID-19 Pandemic Breast Cancer Consortium released recommendations that operations for ductal carcinoma in situ (DCIS) be deferred due to the pandemic.

	Novel biomarkers linked to improved outcomes with immunotherapy in metastatic breast cancer Two novel biomarkers have been found to correlate with improved outcomes with immunotherapy in metastatic breast cancer and may help to identify the patients most likely to benefit from this treatment, according to exploratory studies reported at the ESMO Breast Cancer Virtual Meeting 2020.

Website: www.news-medical.net

Email: [email protected]

Telephone: +44 (0)161 457 7150

AZoNetwork UK Ltd.
NEO, 4th Floor
9 Charlotte Street, Manchester
M1 4ET, UK

Why did you receive this email?
You recently requested related information from us and asked to be notified of additional information.

Not interested anymore?
Unsubscribe or
Update Your Newsletter Subscriptions